Back
Vitro SAB de CV Vs. Nukkleus Industry Stock Comparison
Sell
37
VITOF
Vitro SAB de CV
Last Price:
$0.66
Seasonality Move:
20.41%
Sell
46
NUKK
Nukkleus
Last Price:
$40.15
Seasonality Move:
-21.57%
Sell
37
Vitro SAB de CV (VITOF)
is a Sell
Is Vitro SAB de CV a Buy, Sell or Hold?
-
The current Vitro SAB de CV [VITOF] share price is $0.66. The Score for VITOF is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
VITOF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Nukkleus (NUKK)
is a Sell
Is Nukkleus a Buy, Sell or Hold?
-
NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VITOF Stock Price Chart
What is Vitro SAB de CV's stock price today?
-
The Vitro SAB de CV share price today is $0.66The current trend is relatively stagnant and VITOF is experiencing slight buying pressure.
NUKK Stock Price Chart
VITOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Sell |
Relative Strength Index (14 RSI): | 9.2 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.66 - 0.66) | Sell |
Bollinger Bands (100): | (0.66 - 0.66) | Sell |
NUKK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.69 | Buy |
Relative Strength Index (14 RSI): | 77.28 | Buy |
Chaikin Money Flow: | -1366926 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (-7.5 - 22.6) | Buy |
Bollinger Bands (100): | (-4.22 - 11.5) | Buy |
VITOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.66 | Sell |
20-day SMA: | 0.66 | Sell |
50-day SMA: | 0.66 | Sell |
200-day SMA: | 0.66 | Sell |
8-day EMA: | 0.66 | Sell |
20-day EMA: | 0.66 | Sell |
50-day EMA: | 0.66 | Sell |
200-day EMA: | 0.71 | Sell |
NUKK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.07 | Buy |
20-day SMA: | 9 | Buy |
50-day SMA: | 4.99 | Buy |
200-day SMA: | 4.78 | Buy |
8-day EMA: | 26.51 | Buy |
20-day EMA: | 14.21 | Buy |
50-day EMA: | 7.47 | Buy |
200-day EMA: | 11.77 | Buy |
Vitro SAB de CV Earnings Growth & VITOF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nukkleus Earnings Growth & NUKK Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Vitro SAB de CV Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nukkleus Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |